FeLV Antigen Rapid Test

FeLV Antigen Rapid Test 

 

Type: Uncut Sheet

Brand: Bio-mapper

Catalog:RPA1111

Specimen:WB/S/P

Remarks:BIONOTE Standard

Feline leukemia is a common non-traumatic lethal disease in cats, which is a malignant neoplastic infectious disease caused by feline leukemia virus and feline sarcoma virus. The main features are malignant lymphoma, myeloid leukemia, and degenerative thymus atrophy and non-aplastic anemia, among which the most serious for cats is malignant lymphoma. Kittens have high susceptibility and decrease with age.


Product Detail

Product Tags

Detailed description

Feline leukemia virus (FeLV) is a retrovirus that infects only felines and is not infectious to humans. The FeLV genome has three genes: the env gene encodes the surface glycoprotein gp70 and the transmembrane protein p15E; POL genes encode reverse transcriptase, proteases, and integrases; The GAG gene encodes viral endogenous proteins such as nucleocapsid protein.

FeLV virus consists of two identical RNA strands and related enzymes, including reverse transcriptase, integrase, and protease, wrapped in capsid protein (p27) and the surrounding matrix, with the outermost layer being an envelope derived from the host cell membrane containing gp70 glycoprotein and transmembrane protein p15E.

Antigen detection: immunochromatography detects free P27 antigen. This diagnostic method is highly sensitive but lacks specificity, and antigen test results are negative when cats develop degenerative infection.

When the antigen test is positive but does not show clinical symptoms, complete blood count, blood biochemical test, and urine test can be used to check whether there is abnormality. Compared with cats not infected with FELV, cats infected with FELV are more likely to develop anemia, thrombocytopenic disease, neutropenia, lymphocytosis.

Customized Contents

Customized Dimension

Customized CT Line

Absorbent paper brand sticker

Others Customized Service

Uncut Sheet Rapid Test Manufacturing Process

production


  • Previous:
  • Next:

  • Leave Your Message